儿童起病多发性硬化长期残疾进展
基于瑞典MS注册库的回顾性队列研究,纳入12482例多发性硬化患者,其中549例(4.4%)为儿童起病。儿童起病多发性硬化从发病到达EDSS 3、4、6的时间更长,但达到残疾里程碑的年龄更小。原发进展型病程、发病前5年高复发率及首次复发完全缓解与EDSS 4进展风险相关。
要点
- 儿童起病多发性硬化达残疾里程碑时间更长但年龄更小
- 原发进展型病程与EDSS 4进展风险升高相关(HR 4.63)
- 发病前5年高复发率与EDSS 4进展风险升高相关(HR 5.35)
核心结论
- 儿童起病多发性硬化具有独特的临床病程,应在治疗和管理中予以考虑。
研究设计与样本
- 回顾性队列研究,使用瑞典多发性硬化注册库前瞻性收集的临床信息,纳入12482例多发性硬化患者,其中549例(4.4%)为儿童起病(发病年龄<18岁),其余为成人起病(发病年龄≥18岁)。
主要发现
- 儿童起病多发性硬化从发病到达EDSS 3、4、6的时间均长于成人起病,但达到各残疾里程碑的年龄更小。
- 在儿童起病多发性硬化中,原发进展型病程与进展至EDSS 4的风险相关(HR 4.63;95%CI 1.46-14.7)。
- 发病前5年较高复发率与进展至EDSS 4的风险相关(HR 5.35;95%CI 3.37-8.49)。
- 首次复发完全缓解与进展至EDSS 4的风险相关(HR 0.41;95%CI 0.18-0.94)。
- 上述模式在达到EDSS 3和EDSS 6的风险中同样出现。
临床怎么用
- 临床管理中应认识到儿童起病多发性硬化病程独特:达残疾里程碑时间更长但年龄更小,需长期监测残疾进展。
- 对原发进展型病程或发病前5年高复发率的儿童起病多发性硬化患者,应警惕残疾进展风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate long-term disability progression in pediatric-onset multiple sclerosis (POMS) and compare to adult-onset multiple sclerosis (AOMS). METHODS: This was a retrospective cohort study using prospectively collected clinical information from the Swedish MS Registry. Clinical features were compared and Kaplan-Meier and Cox proportional hazards regression were used to assess the risk of reaching sustained Expanded Disability Status Scale (EDSS) 3, 4, and 6 in POMS (multiple sclerosis [MS] onset <18 years) and AOMS (MS onset ≥18 years). RESULTS: A total of 12,482 persons were included; 549 (4.4%) were classified as POMS. The POMS cohort took longer to reach all 3 disability milestones from their MS onset, but did so at a younger age than the AOMS cohort. Primary progressive course (hazard ratio [HR] 4.63; 95% confidence interval [CI] 1.46-14.7), higher relapse rate in the first 5 years of disease (HR 5.35; 95% CI 3.37-8.49), and complete remission from the initial relapse (HR 0.41; 95% CI 0.18-0.94) were associated with an altered risk of progression to EDSS 4 among POMS cases. The same pattern emerged for the risk of reaching EDSS 3 and 6. CONCLUSIONS: Patients with pediatric-onset MS follow a distinctive clinical course, which should be considered in the treatment and management of the disease.
引用
- McKay KA, Hillert J, Manouchehrinia A, et al. Long-term disability progression of pediatric-onset multiple sclerosis. Neurology. 2019. PMID: 31092624. doi:10.1212/WNL.0000000000007647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。